Retinopathy

References

Altomare, E., Grattagliano, I., Vendemaile, G., Micelli-Ferrari, T., Signorile, A., Cardia, L. Oxidative protein damage in human diabetic eye: evidence of a retinal participation. Eur. J. Clin. Invest. 1997 Feb; 27(2): 141-7.

Anon. Vitamins for seeing. Compr. Ther. 1990; 16(4): 62.

Bernstein, P.S., Khachik, F., Carvalho, L.S., Muir, G.J., Zhao, D.Y., Katz, N.B. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp. Eye Res. 2001 Mar; 72(3): 215-23.

Boehm, B.O., Lustig, R.H. Use of somatostatin receptor ligands in obesity and diabetic complications. Best Pract. Res. Clin. Gastroenterol. 2002 Jun; 16(3): 493-509.

Bursell, S.E., Clermont, A.C., Aiello, L.P., Aiello, L.M., Schlossman, D.K., Feener, E.P., Laffel, L., King, G.L. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999 Aug; 22(8): 1245-51.

Chung, T.W., Yu, J.J., Liu, D.Z. Reducing lipid peroxidation stress of erythrocyte membrane by alpha-tocopherol nicotinate plays an important role in improving blood rheological properties in type 2 diabetic patients with retinopathy. Diabet. Med. 1998 May; 15(5): 380-5.

Di Giulio, A.M., Lesma, E., Germani, E., Gorio, A. Inhibition of high glucose-induced protein mono-ADP-ribosylation restores neuritogenesis and sodium-pump activity in SY5Y neuroblastoma cells. J. Neurosci. Res. 1999 Sep 1; 57(5): 663-9.

Gorio, A., Donadoni, M.L., Finco, C., Di Giulio, A.M. Endogenous mono-ADP-ribosylation in retina and peripheral nervous system. Effects of diabetes. Adv. Exp. Med. Biol. 1997; 419: 289-95.

Guillausseau, P.J. Pharmacological prevention of diabetic microangiopathy. Diabete Metabol. 1994; 20(2 BIS): 219-28.

Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Hara, T., Fukasawa, H., Kakuta, H., Sakamoto, N. Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats. Eur. J. Pharmacol. 1996; 311(2-3): 199-206.

KaLuzny, J. Antioxidants for prophylaxis of eye diseases. Klin. Oczna 1996 Feb; 98(2): 141-3.

Klein, R., Klein, B.E., Moss, S.E., Cruickshanks, K.J. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch. Intern. Med. 1994 Oct 10; 154(19): 2169-78.

Kowluru, R.A., Kern, T.S., Engerman, R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic. Biol. Med. 1997; 22(4): 587-92.

Leslie, R.D., Pozzilli, P. An introduction to new advances in diabetes. Diabetes Metab. Res. Rev. 2002 Jan-Feb; 18(Suppl. 1): S1-6.

Mayer-Davis, E.J., Bell, R.A., Reboussin, B.A., Rushing, J., Marshall, J.A., Hamman, R.F. Antioxidant nutrient intake and diabetic retinopathy: The San Luis Valley Diabetes Study. Ophthalmology 1998 Dec; 105(12): 2264-70.

Moeller, S.M., Jacques, P.F., Blumberg, J.B. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J. Am. Coll. Nutr. 2000 Oct; 19(5, Suppl.): 522S-527S.

Niesman, M.R., Johnson, K.A., Penn, J.S. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem. Res. 1997 May; 22(5): 597-605.

Papp, A., Nemeth, I., Pelle, Z., Tekulics, P. Prospective biochemical study of the antioxidant defense capacity in retinopathy of premokemiai vizsgalata retinopathia preamaturorumban. Orv. Hetil. 1997 Jan 26; 138(4): 201-5.

Raccah, D., Coste, T., Cameron, N.E., Dufayet, D., Vague, P., Hohman, T.C. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. J. Diabetes Complications 1998 May-Jun; 12(3): 154-62.

Rapp, L.M., Maple, S.S., Choi, J.H. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest. Ophthalmol. Vis. Sci. 2000 Apr; 41(5): 1200-9.

Schalch, W. Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen. EXS 1992; 62: 280-98.

Siems, W.G., Sommerburg, O., van Kuijk, F.J. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors 1999; 10(2-3): 105-13.

Thiagarajan, G., Chandani, S., Sundari, C.S., Rao, S.H., Kulkarni, A.V., Balasubramanian, D. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp. Eye Res. 2001 Sep; 73(3): 393-401.

Wang, A.M., Ma, C., Xie, Z.H., Shen, F. Use of carnosine as a natural anti-senescence drug for human beings. Biochemistry 2000 Jul; 65(7): 869-71.

Yeum, K.J., Shang, F.M., Schalch, W.M., Russell, R.M., Taylor, A. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr. Eye Res. 1999 Dec; 19(6): 502-5.

Zigman, S., Rafferty, N.S., Rafferty, K.A., Lewis, N. Effects of green tea polyphenols on lens photooxidative stress. Biol. Bull. 1999 Oct; 197(2): 285-6.